Protalix Biotherapeutics (PLX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist

1.710
+0.020+1.18%

Close Nov 25 16:00 ET

1.670
-0.040-2.34%

Post 17:08 ET

125.91MMarket Cap-11400P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Protalix BioTherapeutics, Inc. (PLX) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 14 11:35 ET · Conference Call
Protalix BioTherapeutics Reports Profit In Q3; Announces Positive Phase 1 Data For PRX-115
RTTNewsNov 14 07:48 ET
Protalix BioTherapeutics Q3 24 Earnings Conference Call At 8:30 AM ET
RTTNewsNov 14 07:34 ET
Protalix Biotherapeutics | 10-Q: Q3 2024 Earnings Report
SECNov 14 07:07 ET · Announcements
Protalix Biotherapeutics | 8-K: Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results
SECNov 14 07:02 ET
Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $18M
MT NewswiresNov 14 06:52 ET

Comments

Jaguar8

Oct 25 06:43

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024
Protalix BioTherapeutics (NYSE American:PLX) announced it will present data from its phase I clinical trial of PRX-115, a recombinant PEGylated uricase product candidate for uncontrolled gout treatment, at the ACR Convergence 2024. The presentation, titled 'Prolonged Plasma Urate-Lowering After a Single Intravenous Administration of PRX-115,' will be del...

Jaguar8

Jun 13 06:35

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical firm, will host an in-person investor day on June 26, 2024, at the Lotte Palace New York Hotel. The event will begin at 8:30 a.m. EDT. Key opinion leaders, including Aleš Linhart of Charles University and Naomi Schlesinger of the Univers...

Jaguar8

May 29 07:40

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical company specializing in recombinant therapeutic proteins via its ProCellEx® plant cell-based system, announced its participation at the 2024 BIO International Convention in San Diego, California. The convention, hosted by the Biotechnology Innovation Organization (BIO), is the largest industry event, gathering glo...